Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastom...
Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
No major advances have been made in improving overall survival for glioblastoma (GBM) in almost 100 years. The current standard of care (SOC) for GBM involves immediate surgical resection followed by radiotherapy with concomitant temozolomide chemotherapy. Corticosteroid (dexamethasone) is often prescribed to GBM patients to reduce tumor edema and...
Alternative Titles
Full title
Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2216295822
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2216295822
Other Identifiers
ISSN
0364-3190
E-ISSN
1573-6903
DOI
10.1007/s11064-019-02795-4
